Evaluation of the "Platform Model" for Staffing in Psychiatric and Psychosomatic Clinics (EPPIK)

February 10, 2022 updated by: Simone Jennissen, University Hospital Heidelberg

Evaluation of the Suitability of the "Platform Model" as an Instrument for Staffing in Psychiatric and Psychosomatic Clinics (EPPIK) - Subproject Psychosomatics

This study aims to evaluate the so-called platform model and its suitability to determine staffing in hospitals for psychosomatic medicine and psychotherapy.

Study Overview

Status

Recruiting

Detailed Description

The aim of the study is to test the suitability of a structural model (so-called platform model) developed by a working group of various scientific societies and professional associations for staffing in psychosomatic medicine and psychotherapy. For this purpose, in three steps (1.) the four treatment clusters developed in the platform model will be quantified and empirically validated on the basis of the therapeutic services provided in health care practice; (2.) the current staffing for the four treatment clusters will be described ("as-is analysis"); and (3.) prototypical therapy plans will be developed as a basis for estimating the target staffing requirements. On this basis, a target staffing estimate will be made for all professional groups.

For the study, a total of 80 psychosomatic clinics from Germany will be randomly selected, belonging in equal parts to the groups of psychosomatic university clinics, psychosomatic specialist hospitals, and psychosomatic departments in somatic or in psychiatric hospitals. In addition, 20 day clinics are included. In these clinics, the structural framework conditions including staffing will be surveyed and the routine documentation of therapy units will be evaluated by cluster analysis in order to empirically validate the presumed treatment clusters and to describe the necessary staffing requirements.

The empirical examination and validation of the platform model, including the four assumed treatment clusters, has the potential to positively influence care practice in the long term by adjusting staffing levels in psychosomatic clinics to actual care requirements.

Study Type

Observational

Enrollment (Anticipated)

5961

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Baden-Württemberg
      • Heidelberg, Baden-Württemberg, Germany, 69120
        • Recruiting
        • Simone University Jennissen
        • Contact:
        • Contact:
          • Hans-Christoph Friederich, Prof.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

nationwide German population of psychosomatic specialist clinics and departments at University hospitals, general hospitals, or psychiatric hospitals

Description

Inclusion Criteria for Clinics:

  • belong to the predefined nationwide population of psychosomatic specialist clinics and departments
  • randomly selected for inclusion in the study,
  • the clinic management (head physician or comparable) agrees to participation in the study
  • possibility of electronic recording of the qualified therapy units for all treating professional groups.

Inclusion Criteria for Patients:

  • patient treated in one of the selected clinics on the corresponding ward or day clinic
  • at least 18 years old

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Departments for Psychosomatic Medicine at University Clinics
no study interventions, observational group
There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.
Clinics specialized in Psychosomatic Medicine
no study interventions, observational group
There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.
Departments for Psychosomatic Medicine at general hospitals
no study interventions, observational group
There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.
Departments for Psychosomatic Medicine at psychiatric hospitals
no study interventions, observational group
There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Administered Treatments
Time Frame: Week one of treatment: assessment of administered treatment units
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
Week one of treatment: assessment of administered treatment units
Administered Treatments
Time Frame: Week two of treatment: assessment of administered treatment units
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
Week two of treatment: assessment of administered treatment units
Administered Treatments
Time Frame: Week three of treatment: assessment of administered treatment units
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
Week three of treatment: assessment of administered treatment units
Administered Treatments
Time Frame: Week four of treatment: assessment of administered treatment units
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
Week four of treatment: assessment of administered treatment units
Administered Treatments
Time Frame: Week five of treatment: assessment of administered treatment units
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
Week five of treatment: assessment of administered treatment units
Administered Treatments
Time Frame: Week six of treatment: assessment of administered treatment units
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
Week six of treatment: assessment of administered treatment units
Administered Treatments
Time Frame: Week seven of treatment: assessment of administered treatment units
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
Week seven of treatment: assessment of administered treatment units
Administered Treatments
Time Frame: Week eight of treatment: assessment of administered treatment units
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
Week eight of treatment: assessment of administered treatment units

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HONOS - Health of the Nation Outcome Scales
Time Frame: administered once per patient at week one of treatment
measure of severity of mental illness
administered once per patient at week one of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 11, 2021

Primary Completion (Anticipated)

May 31, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

January 31, 2022

First Submitted That Met QC Criteria

February 10, 2022

First Posted (Actual)

February 15, 2022

Study Record Updates

Last Update Posted (Actual)

February 15, 2022

Last Update Submitted That Met QC Criteria

February 10, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • EPPIK

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychosomatic Medicine

Clinical Trials on no intervention, purely observational

3
Subscribe